TransMedics Group Future Growth
Future criteria checks 5/6
TransMedics Group is forecast to grow earnings and revenue by 44.4% and 22.7% per annum respectively. EPS is expected to grow by 44% per annum. Return on equity is forecast to be 18.7% in 3 years.
Key information
44.4%
Earnings growth rate
44.0%
EPS growth rate
Medical Equipment earnings growth | 16.6% |
Revenue growth rate | 22.7% |
Future return on equity | 18.7% |
Analyst coverage | Good |
Last updated | 13 Jun 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 654 | 85 | 133 | 161 | 7 |
12/31/2025 | 528 | 42 | 31 | 76 | 9 |
12/31/2024 | 401 | 29 | -68 | 60 | 9 |
3/31/2024 | 297 | -10 | -230 | -8 | N/A |
12/31/2023 | 242 | -25 | -192 | -13 | N/A |
9/30/2023 | 192 | -36 | -165 | -25 | N/A |
6/30/2023 | 151 | -18 | -41 | -33 | N/A |
3/31/2023 | 119 | -28 | -47 | -36 | N/A |
12/31/2022 | 93 | -36 | -58 | -46 | N/A |
9/30/2022 | 72 | -42 | -61 | -48 | N/A |
6/30/2022 | 51 | -48 | -53 | -43 | N/A |
3/31/2022 | 39 | -47 | -45 | -40 | N/A |
12/31/2021 | 30 | -44 | -32 | -29 | N/A |
9/30/2021 | 28 | -38 | -30 | -29 | N/A |
6/30/2021 | 30 | -30 | -27 | -26 | N/A |
3/31/2021 | 25 | -28 | -30 | -29 | N/A |
12/31/2020 | 26 | -29 | -31 | -30 | N/A |
9/30/2020 | 24 | -32 | -31 | -30 | N/A |
6/30/2020 | 24 | -35 | -30 | -30 | N/A |
3/31/2020 | 26 | -36 | -34 | -33 | N/A |
12/28/2019 | 24 | -34 | -32 | -32 | N/A |
9/28/2019 | 21 | -32 | -31 | -31 | N/A |
6/29/2019 | 18 | -29 | -32 | -32 | N/A |
3/30/2019 | 15 | -26 | -27 | -27 | N/A |
12/29/2018 | 13 | -24 | -26 | -26 | N/A |
9/29/2018 | 12 | -21 | -26 | -25 | N/A |
6/30/2018 | 9 | -20 | -24 | -24 | N/A |
3/31/2018 | 8 | -20 | -23 | -23 | N/A |
12/30/2017 | 8 | -21 | N/A | -23 | N/A |
12/31/2016 | 6 | -24 | N/A | -24 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 8T8 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.7%).
Earnings vs Market: 8T8 is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 8T8 is expected to become profitable in the next 3 years.
Revenue vs Market: 8T8's revenue (22.7% per year) is forecast to grow faster than the German market (5.1% per year).
High Growth Revenue: 8T8's revenue (22.7% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 8T8's Return on Equity is forecast to be low in 3 years time (18.7%).